Results 281 to 290 of about 680,317 (306)

Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study

New England Journal of Medicine, 2007
John D. Rioux, Stephen Sawcer, Bruce A C Cree   +2 more
exaly  

Remyelination therapies: a new direction and challenge in multiple sclerosis

Nature Reviews Drug Discovery, 2017
Wei-Qiao Liu, Voon Wee Yong, Jason R Plemel   +2 more
exaly  

Axonal Transection in the Lesions of Multiple Sclerosis

New England Journal of Medicine, 1998
Bruce D Trapp, Richard M Ransohoff, Richard A. Rudick   +2 more
exaly  

Rate of Pregnancy-Related Relapse in Multiple Sclerosis

New England Journal of Medicine, 1998
Michael Hutchinson, T Moreau, Christian Confavreux   +2 more
exaly  

Multiple Sclerosis — The Plaque and Its Pathogenesis

New England Journal of Medicine, 2006
Elliot Frohman
exaly  

Immunopathology of multiple sclerosis

Nature Reviews Immunology, 2015
Manuel A. Friese, Calliope A. Dendrou, Lars Fugger   +2 more
exaly  

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

New England Journal of Medicine, 2017
Fred D. Lublin, Bernhard Hemmer, Amit Bar-or   +2 more
exaly  

Systemic sclerosis

Journal of the American Academy of Dermatology
Galen T. Foulke, Mackenzie Sennett, Matthew F. Helm   +2 more
openaire   +2 more sources

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

New England Journal of Medicine, 2011
Philippe Truffinet, Giancarlo Comi, Jerry S Wolinsky   +2 more
exaly  

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

New England Journal of Medicine, 2008
Emmanuelle Waubant, Annette M Langer-Gould, Amit Bar-or   +2 more
exaly